We are live on
!
Find out more
TD Asset Management Portfolio holdings
AUM
$123B
1-Year Est. Return
34.51%
This Fund
S&P 500
This Quarter
Est. Return
-15.11%
1 Year Est. Return
+34.51%
3 Year Est. Return
+98.94%
5 Year Est. Return
+122.3%
10 Year Est. Return
+375.56%
AUM
$86.3B
AUM Growth
-$23B
(-21%)
Cap. Flow
-$4.73B
Cap. Flow
% of AUM
-5.48%
Top 10 Holdings %
Top 10 Hldgs %
27.54%
Holding
1,537
New
55
Increased
353
Reduced
823
Closed
80
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$311M |
| 2 |
UnitedHealth
UNH
|
+$143M |
| 3 |
Stryker
SYK
|
+$139M |
| 4 |
Tesla
TSLA
|
+$133M |
| 5 |
Northrop Grumman
NOC
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.77B |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$419M |
| 3 |
Meta Platforms (Facebook)
META
|
+$291M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$258M |
| 5 |
Comcast
CMCSA
|
+$154M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.12% |
| 2 | Technology | 17.73% |
| 3 | Healthcare | 10.68% |
| 4 | Consumer Discretionary | 8.18% |
| 5 | Communication Services | 8.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SVM
1326
Silvercorp Metals
SVM
$2.07B
| $388K | ﹤0.01% |
156,890
-16,203
| -9% | -$49K |
|
|
SWTX
1327
DELISTED
SpringWorks Therapeutics
SWTX
| $384K | ﹤0.01% |
15,616
-5,800
| -27% | -$212K |
|
1328
AdvanSix
ASIX
$541M
| $381K | ﹤0.01% |
+11,400
| New | +$509K |
|
|
CWAN
1329
DELISTED
Clearwater Analytics
CWAN
| $379K | ﹤0.01% |
31,460
-1,628
| -5% | -$26.3K |
|
1330
U-Haul Holding Co
UHAL
$13.9B
| $376K | ﹤0.01% |
7,860
-460
| -6% | -$23.8K |
|
1331
Invesco DB US Dollar Index Bullish Fund
UUP
$420M
| $376K | ﹤0.01% |
13,430
+1,162
| +9% | +$31.9K |
|
1332
HEICO Corp
HEI
$49.8B
| $372K | ﹤0.01% |
2,834
-645
| -19% | -$90.9K |
|
|
TBRG
1333
DELISTED
TruBridge
TBRG
| $368K | ﹤0.01% |
+11,500
| New | +$372K |
|
1334
MeiraGTx Holdings
MGTX
$1.09B
| $367K | ﹤0.01% |
48,431
| – | – |
|
1335
Chewy
CHWY
$9.25B
| $364K | ﹤0.01% |
10,484
-979
| -9% | -$31.4K |
|
1336
Erie Indemnity
ERIE
$12.7B
| $364K | ﹤0.01% |
1,895
-400
| -17% | -$69.6K |
|
|
RETA
1337
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $363K | ﹤0.01% |
11,936
-1,514
| -11% | -$45.2K |
|
1338
Credit Acceptance
CACC
$5.95B
| $347K | ﹤0.01% |
732
-247
| -25% | -$136K |
|
1339
Tenaya Therapeutics
TNYA
$161M
| $347K | ﹤0.01% |
61,644
| – | – |
|
1340
Darling Ingredients
DAR
$9.64B
| $346K | ﹤0.01% |
5,791
-560
| -9% | -$42.5K |
|
1341
National Presto Industries
NPK
$870M
| $341K | ﹤0.01% |
5,200
-4,900
| -49% | -$348K |
|
|
LIAN
1342
DELISTED
LianBio American Depositary Shares
LIAN
| $335K | ﹤0.01% |
154,919
| – | – |
|
1343
UiPath
PATH
$6.61B
| $334K | ﹤0.01% |
18,389
-1,066,186
| -98% | -$19.9M |
|
1344
Regenxbio
RGNX
$620M
| $332K | ﹤0.01% |
13,441
-7,159
| -35% | -$179K |
|
1345
Design Therapeutics
DSGN
$761M
| $331K | ﹤0.01% |
23,618
-20,700
| -47% | -$280K |
|
1346
SOPHiA GENETICS
SOPH
$476M
| $330K | ﹤0.01% |
91,185
-32,633
| -26% | -$166K |
|
1347
Voyager Therapeutics
VYGR
$183M
| $321K | ﹤0.01% |
+54,300
| New | +$367K |
|
1348
CRH
CRH
$63.2B
| $319K | ﹤0.01% |
9,171
-304
| -3% | -$11.8K |
|
|
LEV
1349
DELISTED
The Lion Electric Company
LEV
| $316K | ﹤0.01% |
75,139
-192,551
| -72% | -$1.13M |
|
1350
LXP Industrial Trust
LXP
$3.57B
| $313K | ﹤0.01% |
5,820
| – | – |
|
Similar funds
VAM
TD Asset Management's Q2 2022 Portfolio in Review
As of Q2 2022, TD Asset Management held 1,537 positions worth $86.3B, down 21% from $109B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
TD Asset Management withdrew a net $4.73B in Q2 2022, closing 80 positions and reducing 823 holdings. Its most notable exit was Ortho Clinical Diagnostics Holdings plc Ordinary Shares, an estimated $23.8M position sold in full.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.
Against the trend, TD Asset Management opened a new position in Vanguard Short-Term Corporate Bond ETF worth $25M.
- TD Asset Management's largest Q2 2022 buy was Vanguard Short-Term Corporate Bond ETF: 327,600 shares worth $25M.
- TD Asset Management added most to iShares 20+ Year Treasury Bond ETF in Q2 2022, an estimated $311M increase.
- TD Asset Management's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.77B.
- TD Asset Management fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $23.8M.
- TD Asset Management's ten largest holdings make up 28% of its $86.3B portfolio in Q2 2022.
- TD Asset Management opened 55 new positions and closed 80 in Q2 2022.
- TD Asset Management's portfolio value fell 21% quarter-over-quarter to $86.3B.
Based on TD Asset Management's 13F filing for Q2 2022, filed 4 Aug 2022.